Roche
ROG.SW
$251.91
Share price
1.73%
Change (1 day)
-19.99%
Change (1 year)
Categories
Roche (ROG.SW) - Total debt
Total debt on the balance sheet as of December 2023 : $36.61 B
According to Roche's latest financial reports the company's total debt is $36.61 B. A company’s total debt is the sum of all current and non-current debts.
Roche - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $36.61 B | 27.42% |
| 2022-12-31 | $28.73 B | -19.35% |
| 2021-12-31 | $35.62 B | 103.8% |
| 2020-12-31 | $17.48 B | 8.67% |
| 2019-12-31 | $16.08 B | -15.7% |
| 2018-12-31 | $19.08 B | -2% |
| 2017-12-31 | $19.47 B | -11.27% |
| 2016-12-31 | $21.94 B | -6.75% |
| 2015-12-31 | $23.53 B | -9.53% |
| 2014-12-31 | $26.01 B | 23.79% |
| 2013-12-31 | $21.01 B | -22.01% |
| 2012-12-31 | $26.94 B | -5.87% |
| 2011-12-31 | $28.62 B | -11.01% |
| 2010-12-31 | $32.16 B | -21.57% |
| 2009-12-31 | $41.01 B | 946.05% |
| 2008-12-31 | $3.92 B | -35.36% |
| 2007-12-31 | $6.06 B | -10.48% |
| 2006-12-31 | $6.77 B | -7.81% |
| 2005-12-31 | $7.34 B | -7.79% |
| 2004-12-31 | $7.97 B | -35.53% |
| 2003-12-31 | $12.36 B | -49.51% |
| 2002-12-31 | $24.48 B | -5.82% |
| 2001-12-31 | $25.99 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | -19.88% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | -28.03% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 93.50% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | -57.31% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 76.48% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -44.37% | 🇫🇷 France |
 Becton Dickinson BDX | $16.11 B | -56.00% | 🇺🇸 USA |
 Merck MRK | $35.05 B | -4.25% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | -37.35% | 🇬🇧 UK |